iRadimed appoints John (Jack) Glenn as CFO effective June 20, 2022

IRADIMED CORP

Salary $340,000/year, eligible for annual bonus of 50% of salary.
Receives restricted stock units valued at $750,000, vesting in four equal annual installments.
Prior CFO at Esko Bionics, Sonendo, and other medical device firms.
Glenn is brother-in-law of board member James Hawkins.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

John (Jack) Glenn

Chief Financial Officer

IRMD · IRADIMED CORP

Effective: 2022-06-20
Filed: May 26, 2022, 7:59 PM ET

On May 26, 2022, iRadimed Corporation (the “Company”) issued a press release announcing the appointment of John (Jack) Glenn as Chief Financial Officer of the Company, effective on or before June 20, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

John (Jack) Glenn was appointed as Chief Financial Officer at IRADIMED CORP.

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On May 26, 2022, iRadimed Corporation (the “Company”) issued a press release announcing the appointment of John (Jack) Glenn as Chief Financial Officer of the Company, effective on or before June 20, 2022.

View on SEC.gov

IRADIMED CORP filing history →

Source: SEC EDGAR

accession 0000898432-22-000352

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.